Chromosomal Analysis of Single Cells in Human Embryos

Chromosomal Abnormalities Clinical Trial

Official title:

Chromosomal Analysis of Single Cells in Human Embryos

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT00614367
• Other study ID #: ML4102005
• Status: Active, not recruiting
• Phase: N/A
• First received: January 30, 2008
• Last updated: February 11, 2008
• Start date: October 2005
• Est. completion date: June 2008

Study information

• Verified date: January 2008
• Source: Katholieke Universiteit Leuven
• Contact: n/a
• Is FDA regulated: No
• Health authority: Belgium: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Optimise genetic screening of human embryos using higher resolution techniques

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 30
• Est. completion date: June 2008
• Est. primary completion date: March 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: N/A to 4 Days

Eligibility

Inclusion Criteria:

• 3-4 day old embryos from IVF couples with both partners younger than 36 years old

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Chromosomal Abnormalities
• Chromosome Aberrations
• Chromosome Disorders
• Congenital Abnormalities

Locations

Country	Name	City	State
Belgium	University Hospital Leuven, Catholic University Leuven	Leuven

Sponsors (1)

Lead Sponsor	Collaborator
Katholieke Universiteit Leuven

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	genetic constitution of single blastomeres		3 day old embryos	No